Revolution Medicines, Inc.
(NASDAQ : RVMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc 8.44%5.211.6%$115.69m
VRXValeant Pharmaceuticals International, Inc. 1.78%14.8814.1%$87.56m
PRGOPerrigo Co. Plc -0.56%47.316.8%$86.08m
JAZZJazz Pharmaceuticals Plc 0.02%105.792.3%$83.89m
CTLTCatalent, Inc. 1.08%52.962.2%$75.65m
ICLRICON plc -0.39%144.514.2%$72.97m
UTHRUnited Therapeutics Corp. 0.04%95.8014.3%$71.73m
HZNPHorizon Therapeutics Plc -4.09%30.656.5%$69.77m
AXSMAxsome Therapeutics, Inc. -6.76%49.931.9%$60.79m
GWPHGW Pharmaceuticals Plc 5.57%91.406.2%$58.46m
ICPTIntercept Pharmaceuticals, Inc. 2.48%64.4116.8%$43.10m
SAGESAGE Therapeutics, Inc. 2.17%28.998.6%$40.73m
PBHPrestige Consumer Healthcare, Inc. -1.51%38.584.0%$35.13m
PCRXPacira Biosciences, Inc. 6.47%34.0710.4%$32.15m
MYOKMyoKardia, Inc. -1.10%47.522.1%$26.46m

Company Profile

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.